Prof. Jiafu Ji
✓ Available through China Expert Care
Academician of the Chinese Academy of Engineering; Professor and Chief Physician
Gastrointestinal Cancer Center, Peking University Cancer Hospital

Focus: Surgery and multimodality treatment of stomach cancer
Prof. Ji is a gastrointestinal cancer surgeon at Peking University Cancer Hospital and was elected to the Chinese Academy of Engineering in 2025. Senior author of the RESOLVE phase III trial, which showed that S-1 plus oxaliplatin chemotherapy around or after D2 surgery improved 5-year survival in locally advanced stomach cancer, and of the phase III trial of cadonilimab plus chemotherapy for advanced stomach cancer.
Conditions: Stomach cancer
Selected publications
- Lancet Oncology, 2025 (senior author): Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial. PubMed 39952264
- Nature Medicine, 2025 (senior author): First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial. PubMed 39843940
- JAMA Surgery, 2019 (senior author): Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial. PubMed 31553463
Profile on the hospital website: https://www.bjcancer.org/Html/Doctors/Main/Index_31001.html
Request a written opinion from Prof. Jiafu Ji
Send your records. A medical coordinator will reply within 24 hours.
Start here